SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the following upcoming investor

Aon study shows that Accolade lowered employer claims costs across major clinical categories and risk groups SEATTLE , Feb. 4, 2021 /PRNewswire/ -- Healthcare costs are rising year over year, and this year with the pandemic, uncertainty about costs is higher than ever for employers.

Business leader, healthcare executive and one of Savoy Magazine's 2020 leading executives is driving positive change for the healthcare experience in the U.S. SEATTLE , Jan. 27, 2021 /PRNewswire/ --   Accolade (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help

The addition of 2nd.MD’s Expert Medical Opinion services to Accolade’s portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade’s clinical capabilities and creates the market’s most comprehensive, integrated healthcare navigation experience. SEATTLE, Jan.

SEATTLE, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the 39 th Annual J.P.

Fiscal third quarter 2021 revenue of $38.4 million, a 30% increase compared to fiscal third quarter 2020 revenue of $29.7 million, driven primarily by strength in new customer additions across market segments and offerings  Company raises revenue outlook for fiscal year 2021 to a range of $162